PAH therapy with a TRPC3/6 inhibitor exahibiting good pharmacokinetics

It has been synthesized a stable and specific inhibitor for TRPC3/6 which shows a therapeutic effect on mouse model of Pulmonary Arterial Hypertension (PAH)